Mapping the Developing Beige Fat by Massively Parallel Single Cell Analysis
通过大规模并行单细胞分析绘制米色脂肪发育图
基本信息
- 批准号:9756372
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-06 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdipocytesAdipose tissueAdolescentAdolescent obesityAdultAgeAntibodiesBiological MarkersBiologyBrown FatCardiovascular DiseasesCellsCharacteristicsChildChronicConsumptionCuesDataDefecationDesire for foodDevelopmentDiabetes MellitusEnergy IntakeEnergy MetabolismEnvironmentFDA approvedFatty acid glycerol estersFluorescence-Activated Cell SortingGenerationsGenesGenetic MarkersGoalsHeterogeneityHomeostasisHumanInsulin ResistanceIntestinesKnock-outKnockout MiceLinkMMP3 geneMammalsMammary glandMental DepressionMessenger RNAMetabolicMetabolic DiseasesMethodologyMethodsMitochondriaMorphogenesisMusNatural regenerationNeoplasm MetastasisObesityPathologic ProcessesPharmaceutical PreparationsPharmacologyPhysiologicalPhysiological ProcessesPopulationProliferatingPropertyResearchResolutionRoleSourceSteatorrheaStem cellsStromelysin 1SurveysTestingTherapeuticThermogenesisTissuesVisceralabsorptionadipocyte differentiationagedbasecardiovascular risk factorcell agecell typeimprovedinnovationlipid biosynthesisnovelnovel therapeuticsprogenitorprospectiveside effectsingle cell analysissingle-cell RNA sequencingsubcutaneoustranscriptometranscriptome sequencinguncoupling protein 1
项目摘要
Project Summary/Abstract
Obesity is a primary risk factor for cardiovascular disease and metabolic disorders such as diabetes
mellitus. Obesity and its metabolic consequences continue to be among the most important biomedical
challenges in the U.S. and worldwide today. Nearly one-third of adults (33.8%) and 17% (or 12.5 million) of
children and adolescents are obese in the U.S.. In the absence of improved therapies, further increases are
expected in the number of serious conditions closely associated with obesity. All anti-obesity medications
currently approved by the FDA act to repress energy intake, either by suppressing appetite or by inhibiting
intestinal fat absorption. However, due to side effects including depression, oily bowel movements and
steatorrhea, there is an urgent need for alternative approaches. This study is significant because it may
elucidate new drug to counteract obesity by the completely opposite method, namely, via "increasing" energy
expenditure.
Two types of fat tissue exist in mammals. Brown adipose tissue (BAT) is a specialized adipose tissue
that dissipate energy for heat generation, whereas white adipose tissue (WAT) functions as storage of excess
energy. Studies suggest that loss of BAT is linked to decreased energy expenditure and obesity in humans;
thus “increasing” energy expenditure through regeneration of BAT could be effective to counteract obesity.
Certain physiological cues, such as chronic cold exposure, convert WAT into mitochondria-rich, energy
consuming BAT-like adipocyte. This “browned” adipocyte is referred to as a “beige adipocyte” and recent
studies including ours indicate that adult human BAT is mostly composed of beige adipocytes. The objective of
the proposed research is to determine all subtypes of cells that give rise to beige adipocytes. In this project, I
will focus on cell types that are specific to subcutaneous WAT. It has been known that subcutaneous WAT can
easily be “browned” by external cues, whereas, this conversion is much less observed in a visceral WAT. I
hypothesize that there are discreet cell types in subcutaneous WAT that are predetermined to differentiate to
beige adipocytes. To test this hypothesis, I will employ a novel methodology (single cell RNA sequencing) and
determine the number and characteristics of cell types in subcutaneous and visceral white adipose tissue. I
then identify genetic biomarker for the depot-specific populations. These biomarkers will be used for the
prospective isolation of stem cell of beige adipocytes which contribute to the development of novel cell based
therapeutics or pharmacological strategies to counteract obesity in humans.
项目总结/摘要
肥胖是心血管疾病和代谢紊乱如糖尿病的主要危险因素
糖尿病。肥胖及其代谢后果仍然是最重要的生物医学问题之一,
今天美国和全世界的挑战。近三分之一的成年人(33.8%)和17%(1250万)的
美国的儿童和青少年肥胖。在没有改进的治疗方法的情况下,
与肥胖密切相关的严重疾病的数量。所有抗肥胖药物
目前FDA批准通过抑制食欲或抑制
肠道脂肪吸收。然而,由于副作用,包括抑郁症,油性排便,
然而,迫切需要采取替代办法。这项研究意义重大,因为它可能
阐明新的药物,以完全相反的方法来对抗肥胖,即通过“增加”能量
支出
哺乳动物体内有两种脂肪组织。棕色脂肪组织(BAT)是一种特殊的脂肪组织
而白色脂肪组织(WAT)的功能是储存多余的
能源研究表明,BAT的损失与人类能量消耗减少和肥胖有关;
因此,通过BAT的再生“增加”能量消耗可以有效地对抗肥胖。
某些生理线索,如长期寒冷暴露,将WAT转化为富含维生素A的能量,
消耗BAT样脂肪细胞这种“褐色”脂肪细胞被称为“米色脂肪细胞”,
包括我们在内的研究表明,成年人BAT主要由米色脂肪细胞组成。的目标
这项研究的目的是确定产生米色脂肪细胞的所有细胞亚型。在这个项目中,我
将重点关注皮下WAT特有的细胞类型。已知皮下WAT可以
容易被外部线索“褐化”,而这种转换在内脏WAT中观察到的要少得多。我
假设在皮下WAT中存在预定分化为
米色脂肪细胞。为了验证这一假设,我将采用一种新的方法(单细胞RNA测序),
确定皮下和内脏白色脂肪组织中细胞类型的数量和特征。我
然后确定特定仓库种群的遗传生物标志物。这些生物标志物将用于
米色脂肪细胞干细胞的前瞻性分离有助于开发新的基于细胞的
治疗或药理学策略来对抗人类肥胖。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kosaku Shinoda其他文献
Kosaku Shinoda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kosaku Shinoda', 18)}}的其他基金
Mapping the Developing Beige Fat by Massively Parallel Single Cell Analysis
通过大规模并行单细胞分析绘制米色脂肪发育图
- 批准号:
9978817 - 财政年份:2018
- 资助金额:
$ 24.9万 - 项目类别:
Mapping the Developing Beige Fat by Massively Parallel Single Cell Analysis
通过大规模并行单细胞分析绘制米色脂肪发育图
- 批准号:
9323380 - 财政年份:2016
- 资助金额:
$ 24.9万 - 项目类别:
相似海外基金
Deciphering the role of adipose tissue in common metabolic disease via adipose tissue proteomics
通过脂肪组织蛋白质组学解读脂肪组织在常见代谢疾病中的作用
- 批准号:
MR/Y013891/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
ESTABLISHING THE ROLE OF ADIPOSE TISSUE INFLAMMATION IN THE REGULATION OF MUSCLE MASS IN OLDER PEOPLE
确定脂肪组织炎症在老年人肌肉质量调节中的作用
- 批准号:
BB/Y006542/1 - 财政年份:2024
- 资助金额:
$ 24.9万 - 项目类别:
Research Grant
Canadian Alliance of Healthy Hearts and Minds: Dissecting the Pathways Linking Ectopic Adipose Tissue to Cognitive Dysfunction
加拿大健康心灵联盟:剖析异位脂肪组织与认知功能障碍之间的联系途径
- 批准号:
479570 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Operating Grants
Determinants of Longitudinal Progression of Adipose Tissue Inflammation in Individuals at High-Risk for Type 2 Diabetes: Novel Insights from Metabolomic Profiling
2 型糖尿病高危个体脂肪组织炎症纵向进展的决定因素:代谢组学分析的新见解
- 批准号:
488898 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Operating Grants
Activation of human brown adipose tissue using food ingredients that enhance the bioavailability of nitric oxide
使用增强一氧化氮生物利用度的食品成分激活人体棕色脂肪组织
- 批准号:
23H03323 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of new lung regeneration therapies by elucidating the lung regeneration mechanism of adipose tissue-derived stem cells
通过阐明脂肪组织干细胞的肺再生机制开发新的肺再生疗法
- 批准号:
23K08293 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A study on the role of brown adipose tissue in the development and maintenance of skeletal muscles
棕色脂肪组织在骨骼肌发育和维持中作用的研究
- 批准号:
23K19922 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Adipose Tissue T Cell Polarization and Metabolic Health in Persons Living with HIV
HIV 感染者的脂肪组织 T 细胞极化和代谢健康
- 批准号:
10619176 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Estrogen Signaling in the Ventromedial Hypothalamus Modulates Adipose Tissue Metabolic Adaptation
下丘脑腹内侧区的雌激素信号调节脂肪组织代谢适应
- 批准号:
10604611 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Obesity and Childhood Asthma: The Role of Adipose Tissue
肥胖和儿童哮喘:脂肪组织的作用
- 批准号:
10813753 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别: